Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma

References

• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134–1144. doi:10.1053/j.gastro.2009.02.038
   PubMed Web of Science ®Google Scholar
• Massa A, Varamo C, Vita F, et al. Evolution of the experimental models of cholangiocarcinoma. Cancers (Basel). 2020;12(8):2308. doi:10.3390/cancers12082308
   PubMed Web of Science ®Google Scholar
• Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J Registry Manag. 2011;38(4):201–205.
   PubMedGoogle Scholar
• Van Dyke AL, Shiels MS, Jones GS, et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999–2013. Cancer. 2019;125(9):1489–1498. doi:10.1002/cncr.31942
   PubMed Web of Science ®Google Scholar
• Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019;71(1):104–114. doi:10.1016/j.jhep.2019.03.013
   PubMed Web of Science ®Google Scholar
• Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666–2678. doi:10.1002/cncr.32803
   PubMed Web of Science ®Google Scholar
• Moazzami B, Majidzadeh AK, Dooghaie-Moghadam A, et al. Cholangiocarcinoma: state of the art. J Gastrointest Cancer. 2020;51(3):774–781. doi:10.1007/s12029-020-00390-3
   PubMed Web of Science ®Google Scholar
• Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39 Suppl 1:98–107. doi:10.1111/liv.14086
   PubMed Web of Science ®Google Scholar
• Gondal B, Aronsohn A, Systematic A. Approach to patients with jaundice. Semin Intervent Radiol. 2016;33(4):253–258. doi:10.1055/s-0036-1592331
   PubMed Web of Science ®Google Scholar
• Sullivan JI, Rockey DC. Diagnosis and evaluation of hyperbilirubinemia. Curr Opin Gastroenterol. 2017;33(3):164–170. doi:10.1097/MOG.0000000000000354
   PubMed Web of Science ®Google Scholar
• Abu-Hamda EM, Baron TH. Endoscopic management of cholangiocarcinoma. Semin Liver Dis. 2004;24(2):165–175. doi:10.1055/s-2004-828893
   PubMed Web of Science ®Google Scholar
• Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349–1369.
   PubMed Web of Science ®Google Scholar
• Rizzo A, Ricci AD, Frega G, et al. How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: an updated systematic review and meta-analysis. In Vivo (Brooklyn). 2020;34(4):1701–1714. doi:10.21873/invivo.11964
   PubMed Web of Science ®Google Scholar
• Fellin R, Manzato E. Lipoprotein-X fifty years after its original discovery. Nutr Metab Cardiovasc Dis. 2019;29(1):4–8. doi:10.1016/j.numecd.2018.09.006
   PubMed Web of Science ®Google Scholar
• Kurosawa H, Yoshida H, Yanai H, Ogura Y, Hirowatari Y, Tada N. Comparative study between anion-exchange HPLC and homogeneous assay methods in regard to the accuracy of high- and low-density lipoprotein cholesterol measurement. Clin Biochem. 2007;40(16–17):1291–1296. doi:10.1016/j.clinbiochem.2007.07.008
   PubMed Web of Science ®Google Scholar
• Feingold KR, Grunfeld C. Introduction to Lipids and Lipoproteins. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext. South Dartmouth (MA): MDText.com, Inc. 2000; 22–33.
   Google Scholar
• Beisiegel U. Lipoprotein metabolism. Eur Heart J. 1998;19 Suppl A:A20–A23.
   PubMed Web of Science ®Google Scholar
• Nuno-Lambarri N, Barbero-Becerra VJ, Uribe M, Chavez-Tapia NC. Elevated cholesterol levels have a poor prognosis in a cholestasis scenario. J Biochem Mol Toxicol. 2017;31(1):1–6. doi:10.1002/jbt.21831
   PubMed Web of Science ®Google Scholar
• Basaranoglu S, Agacayak E, Ucmak F, et al. The role of vitamin B1-B2 and plasma lipid profile in intrahepatic cholestasis of pregnancy. J Perinat Med. 2017;45(4):461–465. doi:10.1515/jpm-2015-0337
   PubMed Web of Science ®Google Scholar
• Bonvicini F, Gautier A, Gardiol D, Borel GA. Cholesterol in acute cholestasis induced by taurolithocholic acid. A cytochemical study in transmission and scanning electron microscopy. Lab Invest. 1978;38(4):487–495.
   PubMed Web of Science ®Google Scholar
• Manzato E, Fellin R, Baggio G, Walch S, Neubeck W, Seidel D. Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest. 1976;57(5):1248–1260. doi:10.1172/JCI108393
   PubMed Web of Science ®Google Scholar
• Garcia-Hejl C, Vest P, Renard C, Merens-Gonthier A, Boukhira A, Thefenne-Astier H. Falsely low LDL cholesterol results and cholestasis. Clin Chem. 2006;52(11):2125–2127. doi:10.1373/clinchem.2006.072249
   PubMed Web of Science ®Google Scholar
• Kattah L, Gomez A, Gutierrez S, et al. Hypercholesterolemia due to Lipoprotein X: case report and thematic review. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419878687. doi:10.1177/1179551419878687
   Web of Science ®Google Scholar
• Heimerl S, Boettcher A, Kaul H, Liebisch G. Lipid profiling of lipoprotein X: implications for dyslipidemia in cholestasis. Biochim Biophys Acta. 2016;1861(8 Pt A):681–687. doi:10.1016/j.bbalip.2016.04.016
   PubMed Web of Science ®Google Scholar
• Frohlich J. Role of lecithin: cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro. J Lipid Res. 1995;36(11):2344–2354. doi:10.1016/S0022-2275(20)39715-7
   PubMed Web of Science ®Google Scholar
• Allocca M, Crosignani A, Gritti A, et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut. 2006;55(12):1795–1800. doi:10.1136/gut.2005.079814
   PubMed Web of Science ®Google Scholar